HA
TDOC icon

Harfst & Associates’s Teladoc Health TDOC Stock Holding History

Harfst & Associates’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,121
Closed -$268K – 129
2021
Q3 		$268K Sell
2,121
-12
-0.6% -$1.75K 0.07% 114
2021
Q2 		$354K Sell
2,133
-135
-6% -$21.9K 0.1% 108
2021
Q1 		$412K Buy
+2,268
New +$526K 0.12% 114

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Harfst & Associates's TDOC Position: Q4 2021 in Review

Harfst & Associates sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 2,121 shares — an estimated $268K sold.

Harfst & Associates first reported a position in TDOC in Q1 2021 and held it in 3 quarters. The position peaked at $412K in Q1 2021. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Harfst & Associates reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Harfst & Associates sold 2,121 Teladoc Health shares in Q4 2021, an estimated $268K.
  • Harfst & Associates first reported a position in Teladoc Health in Q1 2021 and held it in 3 quarters.
  • Harfst & Associates's Teladoc Health position peaked at $412K in Q1 2021.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Harfst & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.